These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Clinical features of sarcoidosis associated pulmonary hypertension: Results of a multi-national registry. Baughman RP; Shlobin OA; Wells AU; Alhamad EH; Culver DA; Barney J; Cordova FC; Carmona EM; Scholand MB; Wijsenbeek M; Ganesh S; Birring SS; Kouranos V; O'Hare L; Baran JM; Cal JG; Lower EE; Engel PJ; Nathan SD Respir Med; 2018 Jun; 139():72-78. PubMed ID: 29858005 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. Shin S; King CS; Brown AW; Albano MC; Atkins M; Sheridan MJ; Ahmad S; Newton KM; Weir N; Shlobin OA; Nathan SD Respir Med; 2014 Nov; 108(11):1626-32. PubMed ID: 25225149 [TBL] [Abstract][Full Text] [Related]
10. Distinctive clinical, radiographic, and functional characteristics of patients with sarcoidosis-related pulmonary hypertension. Sulica R; Teirstein AS; Kakarla S; Nemani N; Behnegar A; Padilla ML Chest; 2005 Sep; 128(3):1483-9. PubMed ID: 16162747 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary artery size as a predictor of outcomes in idiopathic pulmonary fibrosis. Shin S; King CS; Puri N; Shlobin OA; Brown AW; Ahmad S; Weir NA; Nathan SD Eur Respir J; 2016 May; 47(5):1445-51. PubMed ID: 26846836 [TBL] [Abstract][Full Text] [Related]
12. Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension. Liu L; Xu J; Zhang Y; Fang L; Chai Y; Niu M; Li S Clin Respir J; 2017 Nov; 11(6):906-914. PubMed ID: 26666961 [TBL] [Abstract][Full Text] [Related]
13. Extrinsic compression of left main coronary artery by the pulmonary trunk secondary to pulmonary hypertension documented using 64-slice multidetector computed tomography coronary angiography. Safi M; Eslami V; Shabestari AA; Saadat H; Namazi MH; Vakili H; Movahed MR Clin Cardiol; 2009 Aug; 32(8):426-8. PubMed ID: 19685513 [TBL] [Abstract][Full Text] [Related]
15. Prevalence of pulmonary hypertension in patients with schistosomal liver fibrosis. Ferreira RC; Domingues AL; Bandeira AP; Markman Filho B; Albuqerque Filho ES; Correiade de Araújo AC; Batista LJ; Markman M; Campelo AR Ann Trop Med Parasitol; 2009 Mar; 103(2):129-43. PubMed ID: 19208297 [TBL] [Abstract][Full Text] [Related]
16. Treatment of sarcoidosis-associated pulmonary hypertension: A single centre retrospective experience using targeted therapies. Keir GJ; Walsh SL; Gatzoulis MA; Marino PS; Dimopoulos K; Alonso R; Raposeiras-Roubin S; Renzoni EA; Maher TM; Wells AU; Wort SJ Sarcoidosis Vasc Diffuse Lung Dis; 2014 Jul; 31(2):82-90. PubMed ID: 25078636 [TBL] [Abstract][Full Text] [Related]
18. An update on sarcoidosis-associated pulmonary hypertension. Bandyopadhyay D; Humbert M Curr Opin Pulm Med; 2020 Sep; 26(5):582-590. PubMed ID: 32740377 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of pulmonary hypertension in pulmonary sarcoidosis: the first large European prospective study. Huitema MP; Bakker ALM; Mager JJ; Rensing BJWM; Smits F; Snijder RJ; Grutters JC; Post MC Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31320453 [No Abstract] [Full Text] [Related]
20. 18F-FDG PET as a predictor of pulmonary function in sarcoidosis. Keijsers RG; Verzijlbergen EJ; van den Bosch JM; Zanen P; van de Garde EM; Oyen WJ; Grutters JC Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):123-9. PubMed ID: 22117503 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]